These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 19478480)
1. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. Allegra A; Alonci A; Penna G; D'Angelo A; Rizzotti P; Granata A; Musolino C Acta Haematol; 2009; 121(4):218-20. PubMed ID: 19478480 [TBL] [Abstract][Full Text] [Related]
2. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature. Michiels JJ; Commandeur S; Hoogenboom GJ; Wegman JJ; Scholten L; van Rijssel RH; De Raeve H Ann Hematol; 2007 Nov; 86(11):793-800. PubMed ID: 17687555 [TBL] [Abstract][Full Text] [Related]
3. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF). Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Janus Kinase 2 mutations in patients with unusual site venous thrombosis. Basquiera AL; Tabares AH; Soria N; Salguero M; Ryser R; García JJ Medicina (B Aires); 2011; 71(4):313-6. PubMed ID: 21893442 [TBL] [Abstract][Full Text] [Related]
5. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis. Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis. Yoo EH; Jang JH; Park KJ; Gwak GY; Kim HJ; Kim SH; Kim DK Int J Lab Hematol; 2011 Oct; 33(5):471-6. PubMed ID: 21435189 [TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia. Weston H; Cowell V; Grimmett K; Saal R; Jones M; Mills T; Gill D; Marlton P; Bird R; Mollee P Intern Med J; 2011 May; 41(5):408-15. PubMed ID: 20681956 [TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation. Colaizzo D; Amitrano L; Guardascione MA; Tiscia GL; D'Andrea G; Longo VA; Grandone E; Margaglione M Thromb Res; 2013 Aug; 132(2):e99-e104. PubMed ID: 23916380 [TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274 [TBL] [Abstract][Full Text] [Related]
12. The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis. Zerjavic K; Zagradisnik B; Lokar L; Krasevac MG; Vokac NK Thromb Res; 2013 Aug; 132(2):e86-93. PubMed ID: 23845539 [TBL] [Abstract][Full Text] [Related]